Polymorphisms in DNA repair pathways may play a relevant role in lung cancer survival in never-smokers. Furthermore, they could be implicated in the response to chemotherapy and toxicity of platinum agents. The aim of this study was to evaluate the influence of various genetic polymorphisms in the BER and NER DNA repair pathways on survival and toxicity in never-smoker LC patients. The study included never-smokers LC cases diagnosed from 2011 through 2019, belonging to the Lung Cancer Research In Never Smokers study. A total of 356 never-smokers cases participated (79% women; 83% adenocarcinoma and 65% stage IV). Survival at 3 and 5 years from diagnosis was not associated with genetic polymorphisms, except in the subgroup of patients who received radiotherapy or chemo-radiotherapy, and presented with ERCC1 rs3212986 polymorphism. There was greater toxicity in those presenting OGG1 rs1052133 (CG) and ERCC1 rs11615 polymorphisms among patients treated with radiotherapy or chemo-radiotherapy, respectively. In general, polymorphisms in the BER and NER pathways do not seem to play a relevant role in survival and response to treatment among never-smoker LC patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713126 | PMC |
| http://dx.doi.org/10.1038/s41598-020-78051-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genetic Polymorphisms of DNA Repair Genes and their Influence on Paclitaxel based Chemotherapy Induced Toxicity Reactions in Breast Cancer Patients.
Asian Pac J Cancer Prev
December 2024
Department of Oncology, Krishna Vishwa Vidyapeeth "Deemed to be University", Taluka-Karad, Dist- Satara, Pin-415 539, (Maharashtra) India.
Background: Systemic chemotherapy constitutes an indispensable component of breast cancer (BC) management, where therapeutic drug combinations such as anthracyclines, platinum compounds, and taxanes form the cornerstone of standard treatment protocols. Although DNA repair genes are pivotal in cancer susceptibility, their specific roles in mediating acute or chronic toxicity outcomes induced by chemotherapy remain undetermined. Consequently, this study was planned to elucidate the impact of polymorphisms in base excision repair (BER) genes, including XRCC1, XRCC2, XRCC3, APE1, and hOGG1, on treatment response and toxicity outcomes in BC patients undergoing paclitaxel and doxorubicin-based chemotherapy within an Indian population.
View Article and Find Full Text PDFAPEX1 Polymorphisms Affect Acute Myeloid Leukemia Risk, and Its Expression Is Involved in Cell Proliferation and Differentiation.
Int J Lab Hematol
November 2024
Department of Laboratory Science, Graduate School of Health Sciences, Gunma University, Maebashi, Japan.
Article Synopsis
- Researchers explored the connection between DNA repair gene polymorphisms, specifically in base excision repair (BER) genes, and the risk of developing acute myeloid leukemia (AML).
- A significant association was found between the APEX1-656 T>G polymorphism and AML risk, with elevated expression of APEX1 observed in AML patients compared to healthy controls.
- The study concluded that APEX1 polymorphisms may be a risk factor for AML and emphasized APEX1's role in controlling AML cell differentiation and growth.
The Human 8-oxoG DNA Glycosylase 1 () 326 Polymorphism in Infertile Men.
Biomedicines
October 2024
Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
Article Synopsis
- 8-OHdG is a marker of oxidative DNA damage linked to oxidative stress, which may play a role in male infertility, and the enzyme OGG1 is crucial for repairing this damage.
- The study examined the OGG1 326 polymorphism's impact on DNA oxidation in 118 infertile men, utilizing genetic screening, 8-OHdG quantification, and electrical bioimpedance analysis.
- Findings revealed that carriers of the 326 (GG) genotype had significantly higher levels of oxidative DNA damage and lower antioxidant capacity, suggesting a potential link to male infertility in American populations.
Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy.
Mol Neurodegener
August 2024
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Article Synopsis
- Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease linked to abnormal tau protein accumulation, and previous studies were limited in exploring rare genetic variants due to the use of genotype arrays.* -
- In this study, whole genome sequencing (WGS) on a large cohort allowed researchers to confirm known genetic loci related to PSP and discover new associations, particularly highlighting a different role for the APOE ε2 allele compared to Alzheimer's disease.* -
- The findings expand knowledge of PSP's genetic underpinnings and identify potential targets for future research into the disease's mechanisms and treatments.*
Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women.
Breast Cancer Res Treat
November 2024
Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Article Synopsis
- Breast cancer rates are rising rapidly in East Asia, especially among premenopausal women, potentially linked to estrogen-DNA adducts.
- The study involved a case-control setup, where they compared healthy individuals and those with benign breast disease to patients with breast cancer, analyzing specific gene polymorphisms related to DNA repair.
- Results indicated that certain gene variations (APEX1_rs1130409) and higher estrogen-DNA adduct levels significantly increase the risk of breast cancer, particularly in premenopausal women.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!